Hoth Therapeutics Enters into Commercial Licensing Agreement with University of Maryland, Baltimore and Isoprene Pharmaceuticals Inc.

Hoth secures exclusive rights to develop and commercialize therapeutic compounds for dermatological treatments Lead compounds show potent in vivo anti-cancer activity Lead compounds show promise in vitro for treating dermatology conditions Good or... Biopharmaceuticals, Dermatology, Licensing Hoth Therapeutics, Isoprene Pharmaceuticals
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news